-
Je něco špatně v tomto záznamu ?
Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53
D. Strachotová, A. Holoubek, K. Wolfová, B. Brodská, P. Heřman
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2005 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2005-01-01 do Před 1 rokem
Wiley Free Content
od 2005 do Před 1 rokem
PubMed
37119456
DOI
10.1111/febs.16810
Knihovny.cz E-zdroje
- MeSH
- cytoplazma genetika metabolismus MeSH
- jaderné proteiny * genetika metabolismus MeSH
- mutace MeSH
- nádorový supresorový protein p53 * genetika metabolismus MeSH
- nukleofosmin MeSH
- protoonkogenní proteiny c-mdm2 genetika metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Specific C-terminal nucleophosmin (NPM) mutations are related to the acute myeloid leukaemia and cause mistargeting of mutated NPM (NPMmut) to the cytoplasm. Consequently, multiple NPM-interacting partners, e.g., the tumour suppressor p53, become also mislocalized. We found that ubiquitin ligase Mdm2 mislocalizes to the cytoplasm in the presence of NPMmut as well. Since p53 interacts with Mdm2, we searched for the NPMmut-p53-Mdm2 complex and interactions of its constituents in live cells and cell lysates using fluorescently tagged proteins, fluorescence lifetime imaging and immunoprecipitation. We proved existence of the ternary complex, which likely adopts a chain-like configuration. Interaction between Mdm2 and NPMmut was not detected, even under conditions of upregulated Mdm2 and p53 induced by Actinomycin D. We assume that p53 serves in the complex as a bridging link between Mdm2 and NPMmut. This conclusion was supported by disruption of the Mdm2-p53 interaction by Nutlin-3A, which resulted in relocalization of Mdm2 to the nucleus, while both NPMmut and p53 remained in the cytoplasm. Importantly, silencing of p53 also prevented mislocalization of Mdm2 in the presence of NPMmut.
Department of Proteomics Institute of Hematology and Blood Transfusion Prague 2 Czech Republic
Faculty of Mathematics and Physics Institute of Physics Charles University Prague 2 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016444
- 003
- CZ-PrNML
- 005
- 20231026105817.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/febs.16810 $2 doi
- 035 __
- $a (PubMed)37119456
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Strachotová, Dita $u Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague 2, Czech Republic
- 245 10
- $a Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53 / $c D. Strachotová, A. Holoubek, K. Wolfová, B. Brodská, P. Heřman
- 520 9_
- $a Specific C-terminal nucleophosmin (NPM) mutations are related to the acute myeloid leukaemia and cause mistargeting of mutated NPM (NPMmut) to the cytoplasm. Consequently, multiple NPM-interacting partners, e.g., the tumour suppressor p53, become also mislocalized. We found that ubiquitin ligase Mdm2 mislocalizes to the cytoplasm in the presence of NPMmut as well. Since p53 interacts with Mdm2, we searched for the NPMmut-p53-Mdm2 complex and interactions of its constituents in live cells and cell lysates using fluorescently tagged proteins, fluorescence lifetime imaging and immunoprecipitation. We proved existence of the ternary complex, which likely adopts a chain-like configuration. Interaction between Mdm2 and NPMmut was not detected, even under conditions of upregulated Mdm2 and p53 induced by Actinomycin D. We assume that p53 serves in the complex as a bridging link between Mdm2 and NPMmut. This conclusion was supported by disruption of the Mdm2-p53 interaction by Nutlin-3A, which resulted in relocalization of Mdm2 to the nucleus, while both NPMmut and p53 remained in the cytoplasm. Importantly, silencing of p53 also prevented mislocalization of Mdm2 in the presence of NPMmut.
- 650 12
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 650 12
- $a jaderné proteiny $x genetika $x metabolismus $7 D009687
- 650 _2
- $a nukleofosmin $7 D000090243
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a protoonkogenní proteiny c-mdm2 $x genetika $x metabolismus $7 D051736
- 650 _2
- $a cytoplazma $x genetika $x metabolismus $7 D003593
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Holoubek, Aleš $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
- 700 1_
- $a Wolfová, Kateřina $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
- 700 1_
- $a Brodská, Barbora $u Department of Proteomics, Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic $1 https://orcid.org/000000023703594X $7 xx0161159
- 700 1_
- $a Heřman, Petr $u Faculty of Mathematics and Physics, Institute of Physics, Charles University, Prague 2, Czech Republic $1 https://orcid.org/0000000169182576 $7 uk2014827751
- 773 0_
- $w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 290, č. 17 (2023), s. 4281-4299
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37119456 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105811 $b ABA008
- 999 __
- $a ok $b bmc $g 2000141 $s 1202806
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 290 $c 17 $d 4281-4299 $e 20230511 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
- LZP __
- $a Pubmed-20231013